13
Apr 2026
Metformin protects neurons after brain injury by restoring mitochondrial health
TBI remains a major cause of death and long-term neurological disability worldwide, yet effective treatments for secondary injury are still lacking.
Stay Informed!
13
Apr 2026
Protein complex cohesin found essential for guiding cell identity decisions
Temporarily disabling a protein complex that organizes DNA into loops inside the cell's nucleus drastically disrupted the three-dimensional structure of the genome, but surprisingly most genes continued to function as usual, Weill Cornell Medicine researchers found.
13
Apr 2026
Researchers identify molecular link between autoimmune disease and lymphoma risk
Patients with autoimmune diseases such as lupus and rheumatoid arthritis have an increased risk of developing lymphoma, a form of blood cancer that affects the lymphatic system.
13
Apr 2026
Research aims to identify blood biomarkers for predicting Alzheimer's disease
With a NOK 40 million (approx. €3.5 million) grant, Professor Srdjan Djurovic at the University of Oslo aims to identify early blood-based biomarkers that can predict who is at increased risk of developing Alzheimer's disease.
13
Apr 2026
Chinese immigrants use China-based telehealth apps to overcome U.S. barriers
A new peer-reviewed study published in DIGITAL HEALTH finds that a substantial share of recent Chinese immigrants in the United States use China-based telehealth applications for medical advice while living in the U.S., often as a response to barriers within the U.S. healthcare system itself.
13
Apr 2026
NTU Singapore and partners develop new inhaled treatment for severe lung infections
Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB to develop a new inhaled treatment aimed at helping patients recover faster from severe lung infections.
13
Apr 2026
Beckman Coulter Diagnostics earns CE mark for new assay delivering bacterial vs viral infection results in approximately 20 minutes
Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes.
13
Apr 2026
Bayer receives MHRA approval for Kerendia® (finerenone) in adults with heart failure with LVEF ≥ 40 %
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Kerendia® (finerenone), a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), for the treatment of symptomatic chronic heart failure (HF) with left ventricular ejection fraction (LVEF) ≥ 40 %, in adults in the UK.
13
Apr 2026
Obesity health risks differ significantly between men and women
New research being presented at this year's European Congress on Obesity (ECO) in Istanbul, Turkey (12-15 May), reveals distinct patterns of heart, metabolic, and inflammatory health risks between men and women living with obesity, providing an insight into how clinicians may be able to tailor management approaches.
13
Apr 2026
Young cancer survivors face double the risk of later cancers
Survivors of cancer in their teen and young adult years are at double the risk of most types of later cancers, according to research from Alberta published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251381.
